| NCT05499013 | Study to Assess SLN124 in Patients With Polycythemia Vera | RECRUITING | PHASE1, PHASE2 | 2023-01-26 | 2025-06 | 2024-12 |
| NCT05537571 | Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events | COMPLETED | PHASE2 | 2022-12-13 | 2024-07-01 | 2024-01-11 |
| NCT04718844 | A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome | COMPLETED | PHASE1 | 2021-04-14 | 2023-05-23 | 2023-05-23 |
| NCT04606602 | Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) | COMPLETED | PHASE1 | 2020-11-18 | 2023-08-23 | 2023-08-23 |
| NCT04559971 | A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers | COMPLETED | EARLY_PHASE1 | 2020-09-03 | 2021-03-23 | 2021-03-23 |
| NCT04176653 | Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124 | WITHDRAWN | PHASE1 | 2019-08-20 | 2021-10-14 | 2021-09-30 |
| NCT01808638 | Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) | COMPLETED | PHASE1, PHASE2 | 2013-03 | 2016-01 | 2015-08 |
| NCT00938574 | Study With Atu027 in Patients With Advanced Solid Cancer | COMPLETED | PHASE1 | 2009-06 | 2012-09 | 2012-07 |